Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.42 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.42 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.42 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.36 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.31 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.30 |
| ▸ | PRKCG | P05129 | 1/20 | 0.30 |
| ▸ | PRKCB | P05771 | 1/20 | 0.30 |
| ▸ | PRKCA | P17252 | 1/20 | 0.30 |
| ▸ | PRKCH | P24723 | 1/20 | 0.30 |
| ▸ | PRKCI | P41743 | 1/20 | 0.30 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.30 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.30 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.30 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.30 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4773015 | 1.00 | CHRM2 (0.42) | CHRM2CHRM4CHRM5CHRM3ALDH1A1 | |
| SCHEMBL8928379 | 0.98 | ALDH1A1 (0.43) | CHRM2CHRM4CHRM5CHRM3ALDH1A1 | |
| Methyl Alcohol SCHEMBL28701156 | 0.96 | CHRM2 (0.44) | CHRM2CHRM4CHRM5CHRM3ALDH1A1 | |
| SCHEMBL4667952 | 0.94 | CHRM2 (0.44) | CHRM2CHRM4CHRM5CHRM3ALDH1A1 | |
| Oxirane SCHEMBL9245218 | 0.87 | ALDH1A1 (0.52) | ALDH1A1THRBSMN1; SMN2EPHX1PRKD3 | |
| SCHEMBL26986006 | 0.85 | — | — | |
| SCHEMBL928477 | 0.85 | — | — | |
| SCHEMBL8079198 | 0.83 | CHRM2 (0.45) | CHRM2CHRM4CHRM5CHRM3ALDH1A1 | |
| SCHEMBL8071010 | 0.83 | CHRM2 (0.45) | CHRM2CHRM4CHRM5CHRM3ALDH1A1 | |
| Water SCHEMBL5064656 | 0.83 | CHRM2 (0.45) | CHRM2CHRM4CHRM5CHRM3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115308171-A | Preparation method and application of fluorescence/electrochemistry bimodal nanosensor based on covalent organic framework | 江苏大学 | 2022-11-08 | — | — | CN | claimed |
| CN-115165992-A | Construction and application of AuNPs @ COFs-MWCNTs composite material modified electrode | 河北科技大学 | 2022-10-11 | — | — | CN | claimed |
| CN-118895271-A | Functionalized nucleic acid probe, electrochemical biosensor, preparation method and application | 河北科技大学 | 2024-11-05 | — | — | CN | disclosed |
| CN-218766625-U | Fluorescence/electrochemistry bimodal microfluidic detection device | 江苏大学 | 2023-03-28 | — | — | CN | disclosed |
| CN-115308171-A | Preparation method and application of fluorescence/electrochemistry bimodal nanosensor based on covalent organic framework | 江苏大学 | 2022-11-08 | — | — | CN | disclosed |
| CN-114047341-B | Biological probe and biological immunosensor for detecting bungarus venosus and method for detecting bungarus venosus based on proportional signal | 云南大学 | 2022-10-18 | — | — | CN | disclosed |
| CN-115165992-A | Construction and application of AuNPs @ COFs-MWCNTs composite material modified electrode | 河北科技大学 | 2022-10-11 | — | — | CN | disclosed |
| CN-114047341-A | Biological probe and biological immunosensor for detecting bungarus venosus and method for detecting bungarus venosus based on proportional signal | 云南大学 | 2022-02-15 | — | — | CN | disclosed |
| EP-2751094-B1 | NOVEL CRYSTAL FORM | GLAXO GROUP LTD (GB) | 2018-06-20 | — | — | EP | disclosed |
| US-9694004-B2 | Crystal form | GLAXO GROUP LIMITED (GB) | 2017-07-04 | — | — | US | disclosed |
| US-20160367544-A1 | Novel Crystal Form | GLAXO GROUP LIMITED (GB) | 2016-12-22 | — | — | US | disclosed |
| EP-2764866-A1 | Inhibitors of nedd8-activating enzyme | IP Gesellschaft für Management mbH (DE) | 2014-08-13 | — | — | EP | disclosed |
| EP-2751094-A1 | NOVEL CRYSTAL FORM | Glaxo Group Limited (GB) | 2014-07-09 | — | — | EP | disclosed |
| WO-2013030374-A1 | NOVEL CRYSTAL FORM | GLAXO GROUP LIMITED (GB) | 2013-03-07 | — | — | WO | disclosed |
| CN-101709313-B | Method for catalytic synthesizing beta-nitroalcohol compounds by using lipase in organic phase | ZHEJIANG UNIVERSITY (CN) | 2011-12-07 | — | — | CN | disclosed |
| CN-101899052-A | B-crystal form solid matter of bergenin and preparation method and application thereof | INST MATERIA MEDICA CAMS | 2010-12-01 | — | — | CN | disclosed |
| CN-101709313-A | Method for catalytic synthesizing beta-nitroalcohol compounds by using lipase in organic phase | UNIV ZHEJIANG | 2010-05-19 | — | — | CN | disclosed |
| EP-1942892-A1 | SOLID DISPERSIONS OF OPIOID ANTAGONISTS | Adolor Corporation (US) | 2008-07-16 | — | — | EP | disclosed |
| WO-2007044713-A1 | SOLID DISPERSIONS OF OPIOID ANTAGONISTS | ADOLOR CORPORATION (US) | 2007-04-19 | — | — | WO | disclosed |
| US-5037748-A | From phthalic acid or salt using a microorganism, acidification, solvent extraction | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1991-08-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160367544-A1 | Novel Crystal Form | DDX21, NOLC1, GYS2 | CHRM2 3759/4885CHRM4 3518/4885CHRM5 3368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.